Integrichain Blog

Blog

Patient Tokenization Patient Access
Patient Access Afaque Amanulla
June 14, 2021

Frequently Asked Questions – Patient Tokenization

3 Minute Read

Patient tokenization is one of the most mysterious, least understood, and most essential technologies behind actionable patient data. Taken from the Q&A session of IntegriChain's recent Patient Tokenization webinar....

ICyte Platform Josh Halpern
June 3, 2021

Financial Goals to Future Proof Market Access

3 Minute Read

In this four-part series, we examine the key goals of Market Access teams as they look to the future with the advent of speciality and precision medicine and how...

Contracts & Pricing Jillian Murray Brendan Crabtree
May 27, 2021

Making Sense of Co-Pay Offset Programs

4 Minute Read

We dive into the specifics of co-pay offset programs and also examine updates to 340B administrative dispute resolution and ASP reporting as per H.R. 133.

ICyte Platform Josh Halpern
May 20, 2021

Future Proofing Market Access with a Unified Data and Technology Platform

4 Minute Read

This is the first of a series examining the commercial, financial, and operational goals of Market Access, which are all are stymied by data and application silos.

Contracts & Pricing Brendan Crabtree
April 21, 2021

Updates to State Price Transparency Reporting, Medicaid Laws

3 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel John Whitridge
April 14, 2021

The Current State of Drug Price Transparency Reporting

2 Minute Read

What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.

Contracts & Pricing Brendan Crabtree
March 11, 2021

Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule

5 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Brendan Crabtree
February 16, 2021

New ASP Reporting Requirements, 340B Drug Pricing Program and Final Rule,...

4 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Gross-to-Net Nav Devaraj Victoria Wilkinson
January 28, 2021

Five Steps to GTN Implementation Success

3 Minute Read

Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.

Gross-to-Net Jen Sharpe
December 10, 2020

Gross-to-Net Roadmap to Launch

3 Minute Read

A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand